The potential of electrochemical sensors to unveil counterfeits: Xanax as a case study

Abstract

The illicit drug market has been constantly evolving in the last decades, with a significant rise in counterfeit medicines posing serious public health risks. Benzodiazepines (BZDs) such as alprazolam (generally sold under the brand name Xanax), have particularly become the target of counterfeiting efforts due to their addictive nature and upsurge of unregulated designer BZDs. These counterfeit versions frequently resemble legitimate products but contain harmful adulterants or other potent illicit substances. Few methods have been developed to tackle counterfeit pills, usually limited to accurate and sophisticated laboratory equipment. This study explores the feasibility of combining electrochemical fingerprinting with data analysis to overcome the limitations of traditional methods. First, the electrochemical behavior of selected BZDs is studied, and analytical parameters such as pH are optimized. Then, the electroanalysis of common adulterants and illicit drugs is addressed and integrated into a user-friendly app, including a flowchart system. The proposed electrochemical strategy enables the detection of counterfeit Xanax by identifying the presence or absence of alprazolam. It also allows determination of the alprazolam content within a pill while meeting the fundamental requirements of the end users. This study represents an on-site methodology to address the growing challenges posed by BZDs, easily transferable to counterfeit medicines from other drug groups.